Bone Biologics Corporatio... (BBLG)
NASDAQ: BBLG
· Real-Time Price · USD
2.20
-0.15 (-6.38%)
At close: Aug 15, 2025, 2:53 PM
Bone Biologics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -4.26M | -4.11M | -4.14M | -5.12M | -6.1M | -8.95M | -6.51M | -5.8M | -4.51M | -1.48M | -2.56M | -1.85M | -1.87M | -1.61M | -1.89M | -1.77M | -1.66M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 50.00 | 50.00 | 50.00 |
Stock-Based Compensation | 186.74K | 188.82K | 159.2K | 161.29K | 160.52K | 152.6K | 143.97K | 156.47K | 158.55K | 266.63K | 204.33K | 171.8K | 153.05K | 15.21K | 64.69K | 64.69K | 64.69K |
Other Working Capital | 196.44K | -240.03K | -693.59K | -984.85K | -800.18K | -122.95K | -352.75K | -381.61K | -242.04K | -882.66K | -47.72K | 236.8K | 132.03K | 426.16K | 392.14K | 61.43K | 64.53K |
Other Non-Cash Items | 35.48K | -51.08K | -62.88K | -233.5K | -1.49M | -892.69K | -3.05M | -2.89M | -1.62M | -2.18M | -408.46K | -142.91K | 117.11K | 352.93K | 958.93K | 941.6K | 928.91K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 344.27K | -150.25K | -745.18K | -1.58M | -2.07M | 132.92K | -78.78K | 1.21M | 1.91M | -168.37K | 956.97K | 131.49K | -363.1K | 13.96K | -304.44K | -196.82K | 260.85K |
Operating Cash Flow | -3.75M | -4.12M | -4.79M | -6.77M | -9.51M | -9.56M | -9.49M | -7.33M | -4.06M | -3.57M | -1.8M | -1.69M | -1.96M | -1.23M | -1.17M | -961.88K | -405.04K |
Capital Expenditures | 5.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 276.71K | 845.96K | 1.05M | 1.17M | 966.32K | 473.77K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -3.21M | -3.21M | -3.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 5.02M | 5.02M | 5.02M | 436.00 | n/a | n/a | 4.43M | 4.43M | 4.43M | 4.43M | 6.86M | 6.86M | 6.86M | 6.86M | n/a | n/a | n/a |
Financial Cash Flow | 3.27M | 4.42M | 3.9M | 2.1M | 6.55M | 5.04M | 8.88M | 8.88M | 4.43M | 4.43M | 6.86M | 7.14M | 7.7M | 7.9M | 1.17M | 966.32K | 473.77K |
Net Cash Flow | -481.08K | 298.56K | -886.16K | -4.68M | -2.96M | -4.51M | -606.66K | 1.55M | 373.73K | 862.95K | 5.06M | 5.45M | 5.74M | 6.68M | 913.00 | 4.44K | 68.73K |
Free Cash Flow | -3.75M | -4.12M | -4.79M | -6.77M | -9.51M | -9.56M | -9.49M | -7.33M | -4.06M | -3.57M | -1.8M | -1.69M | -1.96M | -1.23M | -1.17M | -961.88K | -405.04K |